SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001176256-20-000403
Filing Date
2020-11-12
Accepted
2020-11-12 07:08:09
Documents
12
Period of Report
2020-11-12

Document Format Files

Seq Description Document Type Size
1 REPORT OF FOREIGN PRIVATE ISSUER FOR THE MONTH OF NOVEMBER, 2020 imv6kq3.htm 6-K 5986
2 INTERIM FINANCIAL STATEMENTS FOR THE PERIOD ENDED SEPTEMBER 30, 2020 exhibit99-1.htm EX-99.1 246626
3 MANAGEMENT DISCUSSION AND ANALYSIS FOR THE PERIOD ENDED SEPTEMBER 30, 2020 exhibit99-2.htm EX-99.2 198985
4 CEO CERTIFICATION exhibit99-3.htm EX-99.3 9607
5 CFO CERTIFICATION exhibit99-4.htm EX-99.4 9418
6 exhibit99-1x1x1.jpg GRAPHIC 17672
7 exhibit99-2x1x1.jpg GRAPHIC 13978
8 exhibit99-2x6x1.jpg GRAPHIC 15037
9 exhibit99-2x7x1.jpg GRAPHIC 157268
10 exhibit99-2x9x1.jpg GRAPHIC 59373
11 exhibit99-2x27x1.jpg GRAPHIC 75619
12 mdax2x1.jpg GRAPHIC 5050
  Complete submission text file 0001176256-20-000403.txt   946352
Mailing Address 130 EILEEN STUBBS AVE. SUITE 19 DARTMOUTH A5 B3B 2C4
Business Address 130 EILEEN STUBBS AVE. SUITE 19 DARTMOUTH A5 B3B 2C4 9024921819
IMV Inc. (Filer) CIK: 0001734768 (see all company filings)

IRS No.: 000000000 | State of Incorp.: Z4 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-38480 | Film No.: 201303313
SIC: 2834 Pharmaceutical Preparations